FOLFOXFOLFIRI5-FUoxaliplatinirinotecanCRCcolorectal cancer
… differential treatment responses (figure 3):First-line therapy FOLFOX: tumor progression in metastatic lesions.Second-line therapy FO…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 241–300 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Broad-spectrum antibiotics6Electroconvulsive therapy6Glucocorticoid therapy6Immune checkpoint blockade therapy6Opioid agonist treatment6Peritoneal dialysis6Pharmacological therapies6Symptomatic treatment6Transcranial Magnetic Stimulation6pharmacological treatments6supportive therapy6therapeutic anticoagulation6therapeutic strategies6TEER5Cholecystectomy5CBT-I5TACE5AHSCT5IVF5POEM5clipping5cryotherapy5Mastectomy5craniotomy5taVNS5ERCP5brachial plexus block5Conventional Physiotherapy5FMT5Antibiotic prophylaxis5CPAP therapy5HRT5Interscalene block5Negative pressure wound therapy5Syndromic management5Laparoscopic cholecystectomy5Neurointerventional surgery5Transcutaneous Auricular Vagus Nerve Stimulation5lipid-lowering therapy5quadruple therapy5Endoscopic submucosal dissection5Endovascular coiling5Lifestyle modifications5Sclerotherapy5precision medicine5ATT5Antihypertensive therapy5Epidural anesthesia5Prophylactic treatment5anti-inflammatory therapy5anticancer treatment5fertility treatment5oral anticoagulation5plasmapheresis5radical prostatectomy5Acceptance and Commitment Therapy5Antiseizure medications5CAR-T cell therapies5Checkpoint blockade5Heart transplantation5
Articles mentioning treatments
7,227 articles · page 229 of 603cancer vaccinesimmune checkpoint inhibitorsCOVID-19CellCartaOlink Reveal10x Genomics
…apies, such as immune checkpoint inhibitors, CAR-T cells, TILs, cancer vaccines, and T cell engagers/redirectors, work by inducing a robust T c…
cancer treatmentFDAInternational Council for HarmonisationFDA-recommended
…he development and quality control of cell therapy products for cancer treatment. As advanced therapies expand into clinical oncology, there is …
81.1%
radioimmunotherapieschimeric antigen receptor (CAR)-T cell therapiescancerOSU cohort3
…ntibodies (mAbs), antibody-drug conjugates (ADCs), bispecifics, radioimmunotherapies, and chimeric antigen receptor (CAR)-T cell therapies. 1 Howeve…
ASP-1929 PITHNSCCcuSCCPembrolizumabNational Institutes of HealthIRDye®700DXASP-1929NIH
…s Across Patients Show Consistent Immune Cell Changes Following ASP-1929 PIT. Uniform Manifold Approximation and Projection (UMAP) plot show…
CAR-T therapySolid tumorsPD-L1-EphA2-4-1BBPD-L1-EphA2-CD28EphA2-PD-L1-4-1BBPD-L1-EphA2EphA2-PD-L1-CD28
…findings support the clinical development of PD-L1-EphA2 tandem CAR-T therapy for treating solid tumors expressing either or both antigens, a…
249 CD3ε enhances CAR-T fitness and persistence by promoting the survival of effector memory T cells
CAR-T therapyCAR-T Cell TherapyB-cell malignanciesAAALAC-approved facilityCAR-T
…Background CAR-T therapy has demonstrated potent anti-tumor efficacy in treating a range…
CAR-T cell therapyCAR T cell therapyPancreatic Ductal Adenocarcinomapancreatic cancerMass General Brighamsolid tumorsMGH Cancer CenterAmerican-Italian Cancer FoundationCRIS Foundation Out-Back Fellowship Programmerotein+2 more
…Background CAR-T cell therapy has shown limited efficacy in solid tumors due to factors such …
CAR-T cell immunotherapiesCAR T cell immunotherapiessolid tumors
…Background CAR-T cell immunotherapies are being avidly pursued for treatment of solid tumors. However…
immune checkpoint blockadestandard treatmentsUniversity Hospital TübingenGerman Cancer Research CenterNUT carcinomaB7-H3NGS Core FacilityOmics IT and Data Management Core FacilityDKFZB7-H3-targeted
…nreported immunologically ‘hot’ NC tumors that may benefit from immune checkpoint blockade and other immunotherapies. To uncover novel actionable targets …
ACTsolid tumorshematologic cancersmetastatic melanomaRNF166
…highlighting a promising strategy for improving the efficacy of ACT.Abstract 277 Figure 1Comprehensive analysis of proteome turnove…
Trispecific NK cell engagersantibody-drug conjugatesUniversity of MinnesotacancerJackson Laboratoryhuman IL-15
…umors and evaluated against various IO therapies such as CAR T, Trispecific NK cell engagers, and antibody-drug conjugates.Results CD34 NSG-FLT3-IL15 mice e…